Douglas S. Micalizzi, Ph.D.

Affiliations: 
2009 University of Colorado Anschutz Medical Campus, Denver, Aurora, CO 
Area:
Molecular Biology, Oncology
Google:
"Douglas Micalizzi"

Parents

Sign in to add mentor
Heide L. Ford grad student 2009 University of Colorado, Denver
 (The role of Transforming Growth Factor-beta and epithelial -to -mesenchymal transition in Six1-induced metastasis.)
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Mishra A, Huang SB, Dubash T, et al. (2025) Tumor cell-based liquid biopsy using high-throughput microfluidic enrichment of entire leukapheresis product. Nature Communications. 16: 32
Brett JO, Dubash TD, Johnson GN, et al. (2023) A Gene Panel Associated With Abemaciclib Utility in -Mutated Breast Cancer After Prior Cyclin-Dependent Kinase 4/6-Inhibitor Progression. Jco Precision Oncology. 7: e2200532
Micalizzi DS, Che D, Nicholson BT, et al. (2022) Targeting breast and pancreatic cancer metastasis using a dual-cadherin antibody. Proceedings of the National Academy of Sciences of the United States of America. 119: e2209563119
Karabacak NM, Zheng Y, Dubash TD, et al. (2022) Differential kinase activity across prostate tumor compartments defines sensitivity to target inhibition. Cancer Research
Micalizzi DS, Ebright RY, Haber DA, et al. (2021) Translational Regulation of Cancer Metastasis. Cancer Research
Ebright RY, Zachariah MA, Micalizzi DS, et al. (2020) HIF1A signaling selectively supports proliferation of breast cancer in the brain. Nature Communications. 11: 6311
Vidula N, Dubash TD, Lawrence MS, et al. (2020) Identification of somatically acquired BRCA1/2 mutations by cfDNA analysis in patients with metastatic breast cancer. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research
Lee S, Micalizzi D, Truesdell SS, et al. (2020) A post-transcriptional program of chemoresistance by AU-rich elements and TTP in quiescent leukemic cells. Genome Biology. 21: 33
Ebright RY, Lee S, Wittner BS, et al. (2020) Deregulation of ribosomal protein expression and translation promotes breast cancer metastasis. Science (New York, N.Y.)
Wander SA, Juric D, Supko JG, et al. (2020) Phase Ib trial to evaluate safety and anti-tumor activity of the AKT inhibitor, ipatasertib, in combination with endocrine therapy and a CDK4/6 inhibitor for patients with hormone receptor positive (HR+)/HER2 negative metastatic breast cancer (MBC) (TAKTIC). Journal of Clinical Oncology. 38: 1066-1066
See more...